公司資料
Fresenius Medical Care Ventures 股價、新聞與催化劑
- 股票代碼:
- FMS
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- Germany and listed in the U
股票表現
22.26 USD (-0.54%)
收盤價
最後更新: 2026年10月1日
11B USD
市值
股價為何變動
截至 2026年10月1日，FMS 下跌 0.54%，收於 $22.26。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Fresenius Medical Care is a global dialysis and kidney-care company focused on renal services, dialysis products, and related healthcare infrastructure. Its business is built around treating chronic kidney disease at scale.
所在地與產業分類
Headquartered in Germany and listed in the U.S. as an ADR, Fresenius Medical Care has a global operating footprint. It sits in healthcare services and dialysis, not biotechnology.
商業模式特徵
The company generates revenue through dialysis treatments, care services, and medical products used in renal care. Investors focus on reimbursement, patient volume, treatment economics, and operational efficiency.
生技產業定位
Fresenius Medical Care is not a biotech name, but it matters to healthcare investors because it sits in a critical chronic-care segment. Its stock is driven by utilization and reimbursement rather than trial data.
未來催化劑
- Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。